1937 related articles for article (PubMed ID: 26706243)
1. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer stem cells: The root of resistance.
MacDonagh L; Gray SG; Breen E; Cuffe S; Finn SP; O'Byrne KJ; Barr MP
Cancer Lett; 2016 Mar; 372(2):147-56. PubMed ID: 26797015
[TBL] [Abstract][Full Text] [Related]
3. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
4. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
5. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
6. Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine.
Yang J; Fang Z; Wu J; Yin X; Fang Y; Zhao F; Zhu S; Li Y
Tumour Biol; 2016 Oct; 37(10):13871-13883. PubMed ID: 27485114
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic approaches targeting cancer stem cells.
Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
[TBL] [Abstract][Full Text] [Related]
8. Liver cancer stem cell markers: Progression and therapeutic implications.
Sun JH; Luo Q; Liu LL; Song GB
World J Gastroenterol; 2016 Apr; 22(13):3547-57. PubMed ID: 27053846
[TBL] [Abstract][Full Text] [Related]
9. NEAT1 contributes to the CSC-like traits of A549/CDDP cells via activating Wnt signaling pathway.
Jiang P; Xu H; Xu C; Chen A; Chen L; Zhou M; Haq IU; Wu X; Mariyam Z; Feng Q
Chem Biol Interact; 2018 Dec; 296():154-161. PubMed ID: 30291867
[TBL] [Abstract][Full Text] [Related]
10. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
Ranji P; Salmani Kesejini T; Saeedikhoo S; Alizadeh AM
Tumour Biol; 2016 Oct; 37(10):13059-13075. PubMed ID: 27561758
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cells: the 'Achilles heel' of chemo-resistant tumors.
Hong IS; Lee HY; Nam JS
Recent Pat Anticancer Drug Discov; 2015; 10(1):2-22. PubMed ID: 25479037
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.
Kumar D; Gorain M; Kundu G; Kundu GC
Mol Cancer; 2017 Jan; 16(1):7. PubMed ID: 28137308
[TBL] [Abstract][Full Text] [Related]
13. Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer.
Yeh CT; Wu AT; Chang PM; Chen KY; Yang CN; Yang SC; Ho CC; Chen CC; Kuo YL; Lee PY; Liu YW; Yen CC; Hsiao M; Lu PJ; Lai JM; Wang LS; Wu CH; Chiou JF; Yang PC; Huang CY
Am J Respir Crit Care Med; 2012 Dec; 186(11):1180-8. PubMed ID: 23024022
[TBL] [Abstract][Full Text] [Related]
14. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells: a potential target for cancer therapy.
Qiu H; Fang X; Luo Q; Ouyang G
Cell Mol Life Sci; 2015 Sep; 72(18):3411-24. PubMed ID: 25967289
[TBL] [Abstract][Full Text] [Related]
16. [Advances in Lung Stem Cells and Lung Cancer Stem Cells].
Yin H; Deng J
Zhongguo Fei Ai Za Zhi; 2015 Oct; 18(10):633-9. PubMed ID: 26483336
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer stem cells and implications for future therapeutics.
Wang J; Li ZH; White J; Zhang LB
Cell Biochem Biophys; 2014 Jul; 69(3):389-98. PubMed ID: 24549856
[TBL] [Abstract][Full Text] [Related]
18. PGE
Lin MC; Chen SY; He PL; Herschman H; Li HJ
Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
[TBL] [Abstract][Full Text] [Related]
19. Can lung cancer stem cells be targeted for therapies?
Wu X; Chen H; Wang X
Cancer Treat Rev; 2012 Oct; 38(6):580-8. PubMed ID: 22436486
[TBL] [Abstract][Full Text] [Related]
20. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
